The Journal of Organic Chemistry
Article
Mp: 239−240 °C. UV−vis (CH2Cl2) λmax (log ε): 311 (4.47), 405 (sh,
and the residue was purified by column chromatography on silica,
eluting initially with chloroform and then with 1−2% methanol/
chloroform. The product fraction was repurified on a second silica
column, affording a dark-green band. Evaporation of the solvent under
reduced pressure gave the oxabenziporphyrin in a partially protonated
form (43.4 mg, 0.081 mmol, 28%) as shiny dark crystals. Mp: >300 °C.
UV−vis (5% Et3N/CH2Cl2) λmax (log ε): 385 (4.29), 637 (3.79). UV−
vis (CH2Cl2) λmax (log ε): 274 (4.62), 377 (4.18), 448 (4.38), 730 (sh,
3.82), 807 (4.13). UV−vis (1% TFA/CH2Cl2) λmax (log ε): 380
(4.27), 454 (4.79), 617 (3.71), 758 (3.87). 1H NMR (500 MHz, TFA/
CDCl3): δ 5.65 (1H, br t, J = 1.5 Hz, 22-H), 6.98 (2H, dd, J = 1.4, 5.0
Hz, 9,18-H), 7.31 (2H, dd, J = 1.5, 7.8 Hz, 2,4-H), 7.48 (2H, s, 13,14-
H), 7.53 (4H, d, J = 7.6 Hz), 7.58 (4H, d, J = 8.0 Hz), 7.62 (4H, t, J =
7.6 Hz), 7.67 (2H, t, J = 7.4 Hz), 7.74 (4H, t, J = 7.8 Hz), 7.81 (2H,
dd, J = 1.6, 5.0 Hz, 8,19-H), 7.85−7.88 (3H, m), 11.24 (2H, br s, 2 ×
NH). 13C NMR (TFA/CDCl3): δ 104.4, 114.5, 129.4, 129.5, 129.7,
131.2, 132.6, 133.2, 134.6, 134.7, 134.8, 135.9, 138.05, 138.08, 138.9,
144.3, 157.5, 163.5. HRMS (ESI) m/z: calcd for C46H30N2O + H,
627.2436; found, 627.2450.
3-tert-Butyl-6,11,16,21-tetraphenyl-24-oxabenziporphyrin
(17d). Furandicarbinol 8b (81.3 mg was reacted with 16b36 (128.7
mg, 0.29 mmol) under the foregoing conditions for 17c to give 17d·
HCl (45.4 mg, 0.080 mmol, 28%) as shiny dark crystals. Mp: >300 °C.
UV−vis (5% Et3N/CH2Cl2) λmax (log ε): 395 (4.25), 445 (sh, 4.06),
602 (3.72). UV−vis (CH2Cl2) λmax (log ε): 265 (4.55), 352 (4.27),
381 (4.09), 452 (4.37), 730 (sh, 3.75), 806 (4.09). UV−vis (1% TFA/
CH2Cl2) λmax (log ε): 352 (4.25), 384 (4.12), 456 (4.68), 768 (3.76).
1H NMR (500 MHz, TFA/CDCl3): δ 1.13 (9H, s, t-Bu), 5.30 (1H, t, J
= 1.5 Hz, 22-H), 7.00 (2H, dd, J = 1.6, 5.1 Hz, 9,18-H), 7.31 (2H, d, J
= 1.4 Hz, 2,4-H), 7.50 (2H, s, 13,14-H), 7.54 (4H, d, J = 7.6 Hz), 7.60
(4H, d, J = 8.0 Hz), 7.63 (4H, t, J = 7.7 Hz), 7.68 (2H, t, J = 7.4 Hz),
7.76 (4H, t, J = 7.9 Hz), 7.83 (2H, dd, J = 1.8, 5.1 Hz, 8,19-H), 7.89
(2H, t, J = 7.5 Hz), 11.05 (2H, s, 2 × NH). 13C NMR (TFA/CDCl3):
δ 30.5, 35.6, 101.7, 114.5, 129.2, 129.5, 129.7, 131.2, 132.7, 134.72,
134.78, 135.7, 136.1, 137.9, 138.6, 138.9, 144.2, 157.3, 158.1, 161.1,
163.3. HRMS (EI) m/z: calcd for C50H38N2O + H, 683.3062; found,
683.3071.
Crystallographic Experimental Details for 13b·0.5C6H14. X-
ray-quality crystals of palladium complex 13b·0.5C6H14 (C45H44N3Pd)
were obtained by vapor diffusion of hexane into a chloroform solution
of the compound. The crystals were suspended in mineral oil at
ambient temperature, and a suitable crystal was selected. The thereby-
obtained mineral-oil-coated red needle with approximate dimensions
of 0.005 mm × 0.01 mm × 0.12 mm was mounted on a 50 μm
MicroMesh MiTeGen micromount and transferred to a Bruker AXS
SMART APEX CCD X-ray diffractometer. The X-ray diffraction data
were collected at 100(2) K using Mo Kα radiation (λ = 0.71073 Å). A
total of 2556 frames were collected. The total exposure time was
127.80 h. The frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm.37 Integration of the data
using a monoclinic unit cell yielded a total of 82 747 reflections to a
maximum θ angle of 29.306° (0.73 Å resolution), of which 9535 were
4.66), 425 (4.89), 499 (sh, 3.58), 535 (3.83), 574 (3.83), 689 (sh,
1
3.51), 747 (3.75), 826 (3.73). H NMR (500 MHz, CDCl3): δ 1.01
(9H, s, t-Bu), 1.43 (6H, t, J = 7.6 Hz, 2 × CH2CH3), 2.98 (4H, q, J =
7.6 Hz, 13,14-CH2), 7.20 (2H, d, J = 5.0 Hz, 8,19-H), 7.32 (2H, s,
11,16-H), 7.37 (2H, d, J = 5.0 Hz, 9,18-H), 7.45−7.53 (6H, m, m-H +
p-H), 7.59−7.61 (4H, m, 4 × o-H), 7.90 (2H, s, 2,4-H). 13C NMR
(CDCl3): δ 16.6, 18.5, 30.6, 34.1, 99.2, 126.4, 127.5, 130.5, 132.5,
134.0, 136.2, 140.5, 142.8, 143.1, 144.0, 145.1, 146.1, 153.1, 157.4.
HRMS (EI) m/z: calcd for C42H37N3Pd, 689.2022; found, 689.2035.
6,11,16,21-Tetraphenyl-24-thiabenziporphyrin (17a). Nitro-
gen was bubbled through a solution of thiophenedicarbinol 16a35
(85.8 mg, 0.29 mmol) and benzitripyrrane 8a (112.5 mg, 0.29 mmol)
in dichloromethane (90 mL) for 10 min, and 200 μL of a 10% BF3·
Et2O solution in dichloromethane was then added. The resulting
solution was stirred in the dark at room temperature under nitrogen
for 2 h. DDQ (194 mg) was added, and the mixture was stirred for a
further 30 min. The mixture was washed with water, and the solvent
was evaporated under reduced pressure. The residue was chromato-
graphed on a grade-2 alumina column, eluting with dichloromethane,
and the product was collected as a bright-green band. Evaporation of
the solvent under reduced pressure gave the thiabenziporphyrin (70.5
mg, 0.11 mmol, 38%) as a dark solid. Mp: >300 °C. UV−vis (1%
Et3N/CH2Cl2) λmax (log ε): 335 (4.40), 411 (4.70), 643 (4.03). UV−
vis (1% TFA/CH2Cl2) λmax (log ε): 346 (4.42), 390 (4.44), 475
1
(5.00), 708 (3.92), 876 (4.19). H NMR (500 MHz, CDCl3): δ 6.62
(2H, d, J = 4.7 Hz, 9,18-H), 7.09 (2H, dd, J = 1.3, 7.7 Hz, 2,4-H), 7.17
(2H, s, 13,14-H), 7.27−7.33 (4H, m), 7.39−7.44 (6H, m), 7.45−7.48
1
(14H, m). H NMR (500 MHz, TFA/CDCl3): δ 5.29 (1H, br s, 22-
H), 7.22 (2H, d, J = 4.9 Hz, 9,18-H), 7.36 (2H, dd, J = 1.2, 7.8 Hz, 2,4-
H), 7.56 (4H, d, J = 7.6 Hz), 7.61 (4H, d, J = 7.6 Hz), 7.64−7.71 (6H,
m), 7.75 (4H, t, J = 7.6 Hz), 7.80 (1H, t, J = 7.8 Hz, 3-H), 7.89 (2H, t,
J = 7.4 Hz), 7.97 (2H, d, J = 4.9 Hz, 8,19-H), 7.98 (2H, s, 13,14-H).
13C NMR (CDCl3): δ 113.0, 126.8, 127.9, 128.4, 128.8, 129.0, 129.89,
129.96, 131.3, 132.8, 133.2, 135.7, 137.1, 138.9, 139.9, 143.1, 147.9,
154.8, 155.0, 172.2. 13C NMR (TFA/CDCl3): δ 100.2, 129.0, 129.5,
129.6, 129.8, 131.7, 132.5, 132.6, 135.0, 135.2, 135.9, 137.7, 138.7,
139.8, 140.0, 142.0, 143.3, 154.4, 156.8, 164.1. HRMS (EI) m/z: calcd
for C46H30N2S, 642.2129; found, 642.2130.
3-tert-Butyl-6,11,16,21-tetraphenyl-24-thiabenziporphyrin
(17b). Using the foregoing procedure for 17a, dicarbinol 16a35 (85.8
mg, 0.29 mmol) was reacted with 8b (128.7 mg, 0.29 mmol) to give
thiabenziporphyrin 17b (61.5 mg, 0.088 mmol, 30%) as a dark solid.
Mp: 210−212 °C (dec). UV−vis (1% Et3N/CH2Cl2) λmax (log ε): 342
(4.37), 416 (4.69), 643 (3.98). UV−vis (1% TFA/CH2Cl2) λmax (log
1
ε): 344 (4.36), 398 (4.43), 477 (4.99), 703 (3.94), 880 (4.16). H
NMR (500 MHz, CDCl3): δ 1.00 (9H, s, t-Bu), 6.64 (2H, d, J = 4.7
Hz, 9,18-H), 7.04 (1H, t, J = 1.5 Hz, 22-H), 7.10 (2H, d, J = 1.5 Hz,
2,4-H), 7.20 (2H, s, 13,14-H), 7.31 (2H, d, J = 4.7 Hz, 8,19-H), 7.39−
1
7.49 (20H, m, 4 × Ph). H NMR (500 MHz, TFA/CDCl3): δ 1.09
(9H, s, t-Bu), 4.95 (1H, t, J = 1.5 Hz, 22-H), 7.23 (2H, d, J = 5.0 Hz,
9,18-H), 7.35 (2H, d, J = 1.5, 2,4-H), 7.57 (4H, d, J = 8.0 Hz), 7.62−
7.71 (10H, m), 7.77 (4H, t, J = 7.8 Hz), 7.90 (2H, t, J = 7.5 Hz), 7.97
(2H, d, J = 5.0 Hz, 8,19-H), 8.00 (2H, s, 13,14-H). 13C NMR
(CDCl3): δ 31.0, 34.7, 110.8, 127.6, 127.9, 128.4, 128.9, 129.6, 129.9,
131.4, 131.5, 133.0, 135.6, 137.2, 139.0, 139.3, 143.4, 148.6, 150.7,
154.69, 154.75, 171.9. 13C NMR (TFA/CDCl3): δ 30.4, 35.5, 98.1,
128.8, 129.2, 129.5, 129.8, 131.6, 132.6, 134.9, 135.4, 135.7, 136.0,
138.4, 139.7, 140.0, 141.9, 143.0, 154.2, 156.6, 157.3, 163.7. HRMS
(EI) m/z: calcd for C50H38N2S, 698.2756; found, 698.2750.
independent (average redundancy 8.678, completeness = 99.9%, Rin2t
=
>
10.82%, Rsig = 7.08%) and 6719 (70.47%) were observed with Fo
2
2σ(Fo ). The final cell constants a = 10.3442(3) Å, b = 29.4631(8) Å, c
= 11.8597(3) Å, β = 105.406(2)°, and volume = 3484.63(17) Å3 are
based upon the refinement of the XYZ centroids of 9379 reflections
above 20σ(I) with 4.5° < 2θ < 53.26°. Limiting indices were as
follows: −14 ≤ h ≤ 14, −40 ≤ k ≤ 40, −16 ≤ l ≤ 16. Data were
corrected for absorption effects using the multiscan method
(SADABS).37 The ratio of minimum to maximum apparent trans-
mission was 0.788 with minimum and maximum SADABS-generated
transmission coefficients of 0.588 and 0.746. Solution and data analysis
were performed using the WinGX software package.38 The structure
was solved and refined in the space group P21/c (No. 14) with Z = 4.39
The solution was achieved by charge-flipping methods using the
program SUPERFLIP,40,41 and the refinement was completed using
the program SHELX2013.42,43 Residual electron density consistent
with disordered hexane was clearly identified, but no suitable model
for the hexane was found. The solvent electron density was near
6,11,16,21-Tetraphenyl-24-oxabenziporphyrin (17c). Nitro-
gen was bubbled through a solution of furandicarbinol 16b36 (81.3 mg,
0.29 mmol) and benzitripyrrane 8a (112.5 mg, 0.29 mmol) in
dichloromethane (90 mL) for 10 min, and 200 μL of a 10% BF3·Et2O
solution in dichloromethane was then added. The resulting solution
was stirred in the dark at room temperature under nitrogen for 2 h.
TFA (2 mL) was added, immediately followed by DDQ (194 mg), and
the mixture was stirred for a further 30 min. The solution was washed
with water, 5% aqueous sodium bicarbonate solution, water, and 10%
hydrochloric acid. The solvent was evaporated under reduced pressure,
9150
dx.doi.org/10.1021/jo401365p | J. Org. Chem. 2013, 78, 9143−9152